newsfilter
← Latest News
GlobeNewswire·

First Patient Dosed in Small Pharma's Phase I Study Exploring Intramuscular Administration of SPL026

LONDON, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV:DMT) (OTCQB:DMTTF) (the "Company" or "Small Pharma"), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health